It has been found that FGF21 is associated with a variety of diseases related to glucose and lipid metabolism, such as obesity, fatty liver, coronary heart disease, atherosclerosis, myocardial infarction, etc (Zhang et al., 2021). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.